TETRAPHASE PHARMACEUTICALS I

CUSIP: 88165N204 Class: COM NEW

UBS Group AG's Holding History (CIK: 0001610520)

Note: Option positions (PUT/CALL) are excluded.

Q2 2020
Shares 2,925 Value ($000) $7 Avg Close — Range —
Q1 2020
Shares 2,925 Value ($000) $4 Avg Close — Range —
Q4 2019
Shares 2,900 Value ($000) $8 Avg Close — Range —
Q3 2019
Shares 2,564 Value ($000) $14 Avg Close — Range —